A nano-hydroxyapatite - Pullulan/dextran polysaccharide composite macroporous material for bone tissue engineering

Biomaterials

Volumn 34, Issue 12, 2013, Pages 2947-2959

  Fricain, Jean Christophe ^a   Schlaubitz, Silke ^b   Le Visage, Catherine ^c   Arnault, Isabelle ^a   Derkaoui, Sidi Mohammed ^c   Siadous, Robin ^a   Catros, Sylvain ^a   Lalande, Charlotte ^a,b   Bareille, Reine ^a   Renard, Martine ^b   Fabre, Thierry ^a   Cornet, Sandro ^b   Durand, Marlène ^b   Léonard, Alain ^d   Sahraoui, Nouredine ^d   Letourneur, Didier ^c   Amédée, Joëlle ^a  

^a University Bordeaux Segalen   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d TEKNIMED   (France)

Author keywords

Bone defect; Bone formation; Mineralization; Nano hydroxyapatite; Osteogenic differentiation; Polysaccharides

Indexed keywords

BONE DEFECT; BONE FORMATION; MINERALIZATION; NANO-HYDROXYAPATITE; OSTEOGENIC DIFFERENTIATION;

BIOMIMETIC MATERIALS; BONE; CELL CULTURE; DEFECTS; HYDROXYAPATITE; MAMMALS; NANOCOMPOSITES; POLYSACCHARIDES; POROUS MATERIALS; TISSUE;

SCAFFOLDS (BIOLOGY);

ACTIN; BONE MORPHOGENETIC PROTEIN 2; HYDROXYAPATITE; OSTEOCALCIN; PULLULAN; TISSUE SCAFFOLD; VASCULOTROPIN 165;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TISSUE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; FEMUR CONDYLE; GOAT; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; OSTEOTOMY; POROSITY; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING; TISSUE REGENERATION;

BASE SEQUENCE; BIOCOMPATIBLE MATERIALS; BONE AND BONES; CELLS, CULTURED; DEXTRANS; DNA PRIMERS; DURAPATITE; GLUCANS; MICROSCOPY, ELECTRON, SCANNING; POLYSACCHARIDES; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; X-RAY DIFFRACTION;

ANIMALIA; CAPRA HIRCUS; MUS; RATTUS;

EID: 84873432870     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.049     Document Type: Article

References (47)

1. Langer R. The evolution of biomaterials. Nat Mater 2009, 8:444-445.
2. Bueno E.M., Glowacki J. Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol 2009, 5:685-697.
3. Chatterjea A., Meijer G., van Blitterswijk C., de Boer J. Clinical application of human mesenchymal stromal cells for bone tissue engineering. Stem Cells Int 2010, 2010:215625.
4. Hollister S.J., Murphy W.L. Scaffold translation: barriers between concept and clinic. Tissue Eng Part B Rev 2011, 17:459-474.
5. Gloria A., De Santis R., Ambrosio L. Polymer-based composite scaffolds for tissue engineering. J Appl Biomater Biomech 2010, 8:57-67.
6. Chang N.J., Lin C.C., Li C.F., Wang D.A., Issariyaku N., Yeh M.L. The combined effects of continuous passive motion treatment and acellular PLGA implants on osteochondral regeneration in the rabbit. Biomaterials 2012, 33:3153-3163.
7. Kim H.W., Gu H.J., Lee H.H. Microspheres of collagen-apatite nanocomposites with osteogenic potential for tissue engineering. Tissue Eng 2007, 13:965-973.
8. Costa-Pinto A.R., Correlo V.M., Sol P.C., Bhattacharya M., Srouji S., Livne E., et al. Chitosan-poly(butylene succinate) scaffolds and human bone marrow stromal cells induce bone repair in a mouse calvaria model. J Tissue Eng Regen Med 2012, 6:21-28.
9. Ghahramanpoor M.K., Hassani Najafabadi S.A., Abdouss M., Bagheri F., Baghaban Eslaminejad M. A hydrophobically-modified alginate gel system: utility in the repair of articular cartilage defects. J Mater Sci Mater Med 2011, 22:2365-2375.
10. Holmbom J., Sodergard A., Ekholm E., Martson M., Kuusilehto A., Saukko P., et al. Long-term evaluation of porous poly(epsilon-caprolactone-co-l-lactide) as a bone-filling material. J Biomed Mater Res A 2005, 75:308-315.
11. Thein-Han W.W., Misra R.D. Biomimetic chitosan-nanohydroxyapatite composite scaffolds for bone tissue engineering. Acta Biomater 2009, 5:1182-1197.
12. Balasundaram G. Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials 2006, 27:2798-2805.
13. Abed A., Assoul N., Ba M., Derkaoui S.M., Portes P., Louedec L., et al. Influence of polysaccharide composition on the biocompatibility of pullulan/dextran-based hydrogels. J Biomed Mater Res A 2011, 96:535-542.
14. Le Visage C, Chaubet F, Autissier A, Letourneur D. Method for preparing porous scaffold for tissue engineering. Patent WO 2009/047346, 2009.
15. Le Visage C, Letourneur D. Method for preparing porous scaffold for tissue engineering, cell culture and cell delivery. Patent WO2009/047347, 2009.
16. Le Visage C., Gournay O., Benguirat N., Hamidi S., Chaussumier L., Mougenot N., et al. Mesenchymal stem cell delivery into rat infarcted myocardium using a porous polysaccharide-based scaffold: a quantitative comparison with endocardial injection. Tissue Eng Part A 2012, 18:35-44.
17. Catros S., Fricain J.C., Guillotin B., Pippenger B., Bareille R., Remy M., et al. Laser-assisted bioprinting for creating on-demand patterns of human osteoprogenitor cells and nano-hydroxyapatite. Biofabrication 2011, 3:025001.
18. Derkaoui S, Le Visage C, Letourneur D, Fricain J, Catros S, Amédée J. Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation. Patent PCT/EP2011/064924, 2010.
19. Autissier A., Le Visage C., Pouzet C., Chaubet F., Letourneur D. Fabrication of porous polysaccharide-based scaffolds using a combined freeze-drying/cross-linking process. Acta Biomater 2010, 6:3640-3648.
20. Leathers T.D. Biotechnological production and applications of pullulan. Appl Microbiol Biotechnol 2003, 62:468-473.
21. Shingel K.I. Current knowledge on biosynthesis, biological activity, and chemical modification of the exopolysaccharide, pullulan. Carbohydr Res 2004, 339:447-460.
22. Lack S., Dulong V., Picton L., Le Cerf D., Condamine E. High-resolution nuclear magnetic resonance spectroscopy studies of polysaccharides crosslinked by sodium trimetaphosphate: a proposal for the reaction mechanism. Carbohydr Res 2007, 342:943-953.
23. Lalande C., Miraux S., Derkaoui S.M., Mornet S., Bareille R., Fricain J.C., et al. Magnetic resonance imaging tracking of human adipose derived stromal cells within three-dimensional scaffolds for bone tissue engineering. Eur Cell Mater 2011, 21:341-354.
24. Afshar A., Ghorbani M., Ehsani N., Saeri M.R., Sorell C.C. Some important factors in the wet precipitation process of hydroxyapatite. Mater Des. 2003, 24:197-203.
25. Sun F., Zhou H., Lee J. Various preparation methods of highly porous hydroxyapatite/polymer nanoscale biocomposites for bone regeneration. Acta Biomater 2011, 7:3813-3828.
26. Supova M. Problem of hydroxyapatite dispersion in polymer matrices: a review. J Mater Sci Mater Med 2009, 20:1201-1213.
27. Boissard C.I., Bourban P.E., Tami A.E., Alini M., Eglin D. Nanohydroxyapatite/poly(ester urethane) scaffold for bone tissue engineering. Acta Biomater 2009, 5:3316-3327.
28. Burns J.S., Rasmussen P.L., Larsen K.H., Schroder H.D., Kassem M. Parameters in three-dimensional osteospheroids of telomerized human mesenchymal (stromal) stem cells grown on osteoconductive scaffolds that predict in vivo bone-forming potential. Tissue Eng Part A 2010, 16:2331-2342.
29. Gothard D., Roberts S.J., Shakesheff K.M., Buttery L.D. Engineering embryonic stem-cell aggregation allows an enhanced osteogenic differentiation in vitro. Tissue Eng Part C Methods 2010, 16:583-595.
30. Barradas A.M., Yuan H., van Blitterswijk C.A., Habibovic P. Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms. Eur Cell Mater 2011, 21:407-429.
31. Li J., Habibovic P., Yuan H., van den Doel M., Wilson C.E., de Wijn J.R., et al. Biological performance in goats of a porous titanium alloy-biphasic calcium phosphate composite. Biomaterials 2007, 28:4209-4218.
32. Miron R.J., Zhang Y.F. Osteoinduction: a review of old concepts with new standards. J Dent Res 2012, 91:736-744.
33. Ripamonti U. Smart biomaterials with intrinsic osteoinductivity: geometric control of bone differentiation. Bone engineering 2000, 215-221. Em Squared Corporation, Toronto, Canada. J.M. Davies (Ed.).
34. Habibovic P., Yuan H., van der Valk C.M., Meijer G., van Blitterswijk C.A., de Groot K. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials 2005, 26:3565-3575.
35. Maire M., Chaubet F., Mary P., Blanchat C., Meunier A., Logeart-Avramoglou D. Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels. Biomaterials 2005, 26:5085-5092.
36. Maire M., Logeart-Avramoglou D., Degat M.C., Chaubet F. Retention of transforming growth factor beta1 using functionalized dextran-based hydrogels. Biomaterials 2005, 26:1771-1780.
37. Billiet T., Vandenhaute M., Schelfhout J., Van Vlierberghe S., Dubruel P. A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering. Biomaterials 2012, 33:6020-6041.
38. Cancedda R., Giannoni P., Mastrogiacomo M. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 2007, 28:4240-4250.
39. Pearce A.I., Richards R.G., Milz S., Schneider E., Pearce S.G. Animal models for implant biomaterial research in bone: a review. Eur Cell Mater 2007, 13:1-10.
40. Schlegel K.A., Lang F.J., Donath K., Kulow J.T., Wiltfang J. The monocortical critical size bone defect as an alternative experimental model in testing bone substitute materials. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 102:7-13.
41. Grellier M., Granja P.L., Fricain J.C., Bidarra S.J., Renard M., Bareille R., et al. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 2009, 30:3271-3278.
42. Malaval L., Monfoulet L., Fabre T., Pothuaud L., Bareille R., Miraux S., et al. Absence of bone sialoprotein (BSP) impairs cortical defect repair in mouse long bone. Bone 2009, 45:853-861.
43. Schimandle J.H., Boden S.D. Spine update. Animal use in spinal research. Spine 1994, 19:2474-2477.
44. Anderson M.L., Dhert W.J., de Bruijn J.D., Dalmeijer R.A., Leenders H., van Blitterswijk C.A., et al. Critical size defect in the goat's os ilium. A model to evaluate bone grafts and substitutes. Clin Orthop Relat Res 1999, 231-239.
45. Dai K.R., Xu X.L., Tang T.T., Zhu Z.A., Yu C.F., Lou J.R., et al. Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcif Tissue Int 2005, 77:55-61.
46. Lamerigts N.M., Buma P., Huiskes R., Schreurs W., Gardeniers J., Slooff T.J. Incorporation of morsellized bone graft under controlled loading conditions. A new animal model in the goat. Biomaterials 2000, 21:741-747.
47. Gliko-Kabir I., Yagen B., Baluom M., Rubinstein A. Phosphated crosslinked guar for colon-specific drug delivery. II. In vitro and in vivo evaluation in the rat. J Control Release 2000, 63:129-134.